这是一篇来自已证抗体库的有关人类 CD226的综述,是根据19篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD226 抗体。
CD226 同义词: DNAM-1; DNAM1; PTA1; TLiSA1

BioLegend
小鼠 单克隆(11A8)
  • 流式细胞仪; 人类; 图 s2
BioLegend CD226抗体(BioLegend, 338312)被用于被用于流式细胞仪在人类样本上 (图 s2). BMC Cancer (2019) ncbi
小鼠 单克隆(11A8)
  • 流式细胞仪; 人类; 图 2a
BioLegend CD226抗体(Biolegend, 11A8)被用于被用于流式细胞仪在人类样本上 (图 2a). Front Immunol (2019) ncbi
小鼠 单克隆(11A8)
  • 流式细胞仪; 人类; 图 s5a
BioLegend CD226抗体(BioLegend, 11A8)被用于被用于流式细胞仪在人类样本上 (图 s5a). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(11A8)
  • 流式细胞仪; 人类; 图 7
BioLegend CD226抗体(Biolegend, 338304)被用于被用于流式细胞仪在人类样本上 (图 7). Sci Rep (2016) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(DX11)
  • 抑制或激活实验; 人类; 图 2
伯乐(Bio-Rad)公司 CD226抗体(Serotec, DX11)被用于被用于抑制或激活实验在人类样本上 (图 2). BMC Cancer (2015) ncbi
碧迪BD
小鼠 单克隆(DX11)
  • 流式细胞仪; 人类; 图 5a
碧迪BD CD226抗体(BD Pharmingen, DX11)被用于被用于流式细胞仪在人类样本上 (图 5a). Front Immunol (2019) ncbi
小鼠 单克隆(DX11)
  • 流式细胞仪; 人类; 图 3b
碧迪BD CD226抗体(BD Pharmingen, DX11)被用于被用于流式细胞仪在人类样本上 (图 3b). Oncoimmunology (2017) ncbi
小鼠 单克隆(DX11)
  • 抑制或激活实验; 人类; 图 5
碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于抑制或激活实验在人类样本上 (图 5). J Exp Med (2017) ncbi
小鼠 单克隆(DX11)
  • 流式细胞仪; 人类
碧迪BD CD226抗体(BD Bioscience, DX11)被用于被用于流式细胞仪在人类样本上. Sci Rep (2017) ncbi
小鼠 单克隆(DX11)
  • 流式细胞仪; 人类; 图 1a
碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
小鼠 单克隆(DX11)
  • 流式细胞仪; 人类; 图 5c
碧迪BD CD226抗体(BD Pharmingen, DX11)被用于被用于流式细胞仪在人类样本上 (图 5c). J Biol Chem (2016) ncbi
小鼠 单克隆(DX11)
  • 流式细胞仪; 人类; 图 1e
碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于流式细胞仪在人类样本上 (图 1e). J Immunol (2016) ncbi
小鼠 单克隆(DX11)
  • 抑制或激活实验; 人类; 图 s9a
  • 流式细胞仪; 人类
碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于抑制或激活实验在人类样本上 (图 s9a) 和 被用于流式细胞仪在人类样本上. Nat Commun (2016) ncbi
小鼠 单克隆(DX11)
  • 流式细胞仪; 人类; 图 2
碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于流式细胞仪在人类样本上 (图 2). Methods Mol Biol (2016) ncbi
小鼠 单克隆(DX11)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD226抗体(BD, 559789)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(DX11)
  • 流式细胞仪; 人类; 表 1
碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于流式细胞仪在人类样本上 (表 1). Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆(DX11)
  • 流式细胞仪; 人类; 图 s1
碧迪BD CD226抗体(BD Biosciences, DX11)被用于被用于流式细胞仪在人类样本上 (图 s1). J Immunol (2015) ncbi
小鼠 单克隆(DX11)
  • 流式细胞仪; 人类
碧迪BD CD226抗体(BD, DX11)被用于被用于流式细胞仪在人类样本上. Eur J Immunol (2015) ncbi
小鼠 单克隆(DX11)
  • 免疫印迹; 人类
碧迪BD CD226抗体(BD, DX11)被用于被用于免疫印迹在人类样本上. Clin Cancer Res (2014) ncbi
文章列表
  1. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed 出版商
  2. Ingegnere T, Mariotti F, Pelosi A, Quintarelli C, De Angelis B, Tumino N, et al. Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing. Front Immunol. 2019;10:957 pubmed 出版商
  3. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed 出版商
  4. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed 出版商
  5. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed 出版商
  6. Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D, et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841 pubmed 出版商
  7. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed 出版商
  8. Kritikou J, Dahlberg C, Baptista M, Wagner A, Banerjee P, Gwalani L, et al. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep. 2016;6:30636 pubmed 出版商
  9. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed 出版商
  10. Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed 出版商
  11. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed 出版商
  12. Kwon H, Choi G, Ryu S, Kwon S, Kim S, Booth C, et al. Stepwise phosphorylation of p65 promotes NF-?B activation and NK cell responses during target cell recognition. Nat Commun. 2016;7:11686 pubmed 出版商
  13. Theorell J, Bryceson Y. Analysis of Intracellular Ca(2+) Mobilization in Human NK Cell Subsets by Flow Cytometry. Methods Mol Biol. 2016;1441:117-30 pubmed 出版商
  14. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  15. Boerman G, van Ostaijen Ten Dam M, Kraal K, Santos S, Ball L, Lankester A, et al. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells. Cancer Immunol Immunother. 2015;64:573-83 pubmed 出版商
  16. Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71 pubmed 出版商
  17. Fionda C, Abruzzese M, Zingoni A, Soriani A, Ricci B, Molfetta R, et al. Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation. BMC Cancer. 2015;15:17 pubmed 出版商
  18. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed 出版商
  19. Sullivan E, Jeha S, Kang G, Cheng C, Rooney B, Holladay M, et al. NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease. Clin Cancer Res. 2014;20:5986-94 pubmed 出版商